Rebel Annette, Ulatowski John A, Kwansa Herman, Bucci Enrico, Koehler Raymond C
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, 600 N. Wolfe St., Baltimore, MD 21205, USA.
Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1600-8. doi: 10.1152/ajpheart.00077.2003. Epub 2003 Jun 19.
The effect of transfusing a nonextravasating, zero-link polymer of cell-free hemoglobin on pial arteriolar diameter, cerebral blood flow (CBF), and O2 transport (CBF x arterial O2 content) was compared with that of transfusing an albumin solution at equivalent reductions in hematocrit (approximately 19%) in anesthetized cats. The influence of viscosity was assessed by coinfusion of a high-viscosity solution of polyvinylpyrrolidone (PVP), which increased plasma viscosity two- to threefold. Exchange transfusion of a 5% albumin solution resulted in pial arteriolar dilation, increased CBF, and unchanged O2 transport, whereas there were no significant changes over time in a control group. Exchange transfusion of a 12% polymeric hemoglobin solution resulted in pial arteriolar constriction and unchanged CBF and O2 transport. Coinfusion of PVP with albumin produced pial arteriolar dilation that was similar to that obtained with transfusion of albumin alone. In contrast, coinfusion of PVP with hemoglobin converted the constrictor response to a dilator response that prevented a decrease in CBF. Pial arteriolar dilation to hypercapnia was unimpaired in groups transfused with albumin or hemoglobin alone but was attenuated in the largest vessels in albumin and hemoglobin groups coinfused with PVP. Unexpectedly, hypocapnic vasoconstriction was blunted in all groups after transfusion of albumin or hemoglobin alone or with PVP. We conclude that 1) the increase in arteriolar diameter after albumin transfusion represents a compensatory response that prevents decreased O2 transport at reduced O2-carrying capacity, 2) the decrease in diameter associated with near-normal O2-carrying capacity after cell-free polymeric hemoglobin transfusion represents a compensatory mechanism that prevents increased O2 transport at reduced blood viscosity, 3) pial arterioles are capable of dilating to an increase in plasma viscosity when hemoglobin is present in the plasma, 4) decreasing hematocrit does not impair pial arteriolar dilation to hypercapnia unless plasma viscosity is increased, and 5) pial arteriolar constriction to hypocapnia is impaired at reduced hematocrit independently of O2-carrying capacity.
在麻醉猫中,将一种无外渗、零交联的游离血红蛋白聚合物输注对软脑膜小动脉直径、脑血流量(CBF)和氧运输(CBF×动脉血氧含量)的影响,与输注白蛋白溶液在等效降低血细胞比容(约19%)时的影响进行了比较。通过同时输注聚乙烯吡咯烷酮(PVP)的高粘度溶液来评估粘度的影响,该溶液使血浆粘度增加两到三倍。输注5%白蛋白溶液进行换血导致软脑膜小动脉扩张、CBF增加且氧运输不变,而对照组随时间无显著变化。输注12%聚合血红蛋白溶液进行换血导致软脑膜小动脉收缩且CBF和氧运输不变。PVP与白蛋白同时输注产生的软脑膜小动脉扩张与单独输注白蛋白相似。相比之下,PVP与血红蛋白同时输注将收缩反应转变为扩张反应,从而防止了CBF降低。单独输注白蛋白或血红蛋白的组中,软脑膜小动脉对高碳酸血症的扩张未受损害,但在与PVP同时输注的白蛋白和血红蛋白组的最大血管中减弱。出乎意料的是,单独输注白蛋白或血红蛋白或与PVP一起输注后,所有组中低碳酸血症性血管收缩均减弱。我们得出结论:1)输注白蛋白后小动脉直径增加代表一种代偿反应,可防止在氧携带能力降低时氧运输减少;2)输注游离聚合血红蛋白后与接近正常氧携带能力相关的直径减小代表一种代偿机制,可防止在血液粘度降低时氧运输增加;3)当血浆中存在血红蛋白时,软脑膜小动脉能够因血浆粘度增加而扩张;4)降低血细胞比容不会损害软脑膜小动脉对高碳酸血症的扩张,除非血浆粘度增加;5)在血细胞比容降低时,软脑膜小动脉对低碳酸血症的收缩受损,与氧携带能力无关。